Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-cameral Penetration of Ganciclovir Following Topical Administration of 0.15% Ganciclovir Gel (VIRGAN©) for CMV Anterior Uveitis / Endotheliitis

NCT01647529 is registered in ClinicalTrials.gov with Singapore National Eye Centre as lead sponsor.

NCT NCT01647529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01647529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-cameral Penetration of Ganciclovir Following Topical Administration of 0.15% Ganciclovir Gel (VIRGAN©) for CMV Anterior Uveitis / Endotheliitis
Lead sponsor
Singapore National Eye Centre
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
July 31, 2014
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior uveitis, cytomegalovirus anterior segment infection, endotheliitis